drugset / Trial / NCT01293552

Clinical Trial To Evaluate ANT-1207 In Subjects With Acne

NCT01293552 ↗

Phase 2 Completed 72 enrolled Anterios Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne.

Timeline

Start
2011-01
Primary completion
2012-04
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — —

Indications